RAJKUMAR VENKATRAMANI to Neuroblastoma
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Neuroblastoma.
Connection Strength
0.201
-
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
Score: 0.120
-
Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma. Pediatr Hematol Oncol. 2015 Feb; 32(1):26-31.
Score: 0.081